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Abstract
Preterm birth is a complex disorder defined by gestations of less than 37 weeks. While preterm birth is estimated to have a
significant genetic component, relative few genes have been associated with preterm birth. Polymorphism in one such
gene, follicle-stimulating hormone receptor (FSHR), has been associated with preterm birth in Finnish and African American
mothers but not other populations. To refine the genetic association of FSHR with preterm birth we conducted a fine-
mapping study at the FSHR locus in a Finnish cohort. We sequenced a total of 44 kb, including protein-coding and
conserved non-coding regions, in 127 preterm and 135 term mothers. Overall, we identified 288 single nucleotide variants
and 65 insertion/deletions of 1–2 bp across all subjects. While no common SNPs in protein-coding regions were associated
with preterm birth, including one previously associated with timing of fertilization, multiple SNPs spanning the first and
second intron showed the strongest associations. Analysis of the associated SNPs revealed that they form both a protective
(OR= 0.50, 95% CI = 0.25–0.93) as well as a risk (OR= 1.89, 95% CI = 1.08–3.39) haplotype with independent effects. In these
haplotypes, two SNPs, rs12052281 and rs72822025, were predicted to disrupt ZEB1 and ELF3 transcription factor binding
sites, respectively. Our results show that multiple haplotypes at FSHR are associated with preterm birth and we discuss the
frequency and structure of these haplotypes outside of the Finnish population as a potential explanation for the absence of
FSHR associations in some populations.
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Introduction
Preterm birth is a complex disorder affecting 12% of
pregnancies in the US [1]. While the causes of spontaneous
preterm labor are not well understood, multiple lines of evidence
indicate a significant genetic contribution. Twin studies estimate
that the length of gestation has a maternal heritability of 15–40%
[2–5]. Prior history of post-term as well as preterm delivery is a
strong predictor of the length of gestation in a subsequent
pregnancy [6], [7]. Preterm birth also clusters among siblings [6],
[8], across generations in kinships [9] and by race [10], [11].
Despite significant genetic effects, genes associated with risk of
preterm birth have been difficult to identify. The majority of
genetic association studies have involved targeted candidate genes
and, while some associations have been found, replicated
associations are rare [12]. Currently, genome-wide association
studies are underway [13] and there have already been new
reported associations [14]. However, replication in independent
cohorts is challenging as population structure related to different
racial groups can lead to false positives in an initial screen and false
negatives in a replication study. Indeed, the length of normal
gestation as well as the rate of preterm birth differs across races
[10], [11], [15].
Previous work identified follicle-stimulating hormone receptor
(FSHR) as a candidate gene for preterm birth based on an
accelerated rate of evolution in humans compared to other
mammals [16]. While polymorphism at FSHR was associated with
preterm birth in a Finnish as well as an African American
population, no associations were found in either a European
American or Hispanic American population [16]. The lack of
associations in these latter two groups could be a consequence of
genetic differences between these populations, either because of
the frequency of the risk variant or its interaction with genetic
background. However, such heterogeneous associations might also
reflect a false positive association. Delineating what effects FSHR
might have on preterm birth and in what populations relies in part
on knowing which variants might alter FSHR function or, at the
least, those variants most strongly associated with preterm birth.
In females, FSHR is required for ovarian and follicular
development and loss of FSHR causes infertility [17]. While FSHR
is primarily expressed in the ovary [18], it may also have functions
in the uterus or cervix [19–22] that could influence the initiation of
labor. However, FSHR may also influence the length of gestation
by its effects on the quality of implantation, which is associated
with a number of adverse pregnancy outcomes including preterm
labor [23]. Another possibility is that FSHR influences the timing
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of fertilization. A common SNP in FSHR (S680N) is associated
with time to ovulation and length of the menstrual cycle [24].
Because the length of gestation is measured from the date of birth
to an estimated date of fertilization based on the last menstrual
period combined with ultrasound, the timing of fertilization could
lead to the appearance of slightly altered gestation lengths.
To fine-map the association of FSHR with preterm birth and
identify potentially functional variants, we sequenced coding and
conserved non-coding regions in Finnish preterm and term
mothers. We find that neither common nonsynonymous SNPs,
including one associated with altered menstrual cycles, nor the
aggregate burden of rare variants is associated with preterm birth.
The strongest associations are concentrated in introns 1 and 2 and
haplotype analysis of this region revealed both a risk and
protective haplotype with statistically independent effects. Our
analysis of these data reveals both candidate functional variants as
well as insight into the population heterogeneity in associations
between FSHR and preterm birth.
Results
Identification of Genetic Variants in FSHR Coding and
Non-coding Regions
To identify potentially causal variants underlying the genetic
association of FSHR with preterm birth, 67 candidate regions were
sequenced in 127 preterm and 135 term Finnish mothers
(Materials and Methods). The sequenced regions cover a total of
17 kb of sequence within candidate regions and an additional
27 kb of sequence flanking the candidate regions. The candidate
regions include FSHR protein-coding regions as well as any non-
coding regions likely to be functional. Non-coding regions were
selected based on experimental evidence from the literature,
sequence conservation across placental mammals using PhastCons
[25], or rapid evolution along the human lineage [16]. Rapidly
evolved sequences are of particular interest since they may have
influenced changes in the length of gestation during human
evolution [16].
Using next-generation sequencing technology, we applied a
pooled high-throughput sequencing protocol [26] to sequence the
target regions in pools of cases and controls. In total we identified
281 high-quality variants and an additional 72 lower-quality
variants (Table 1). The lower quality of some variants can be
attributed to either their low frequencies or low read coverage.
Nevertheless, we found high power to detect rare variants (see
Methods) and accurate estimates of allele frequencies in compar-
ison to those obtained by genotyping (Pearson’s correlation
coefficient = 0.99) (Figure 1).
Genetic Variants Altering Protein Sequence
We did not find any frame-shift, splice-site, or nonsense variants
in FSHR. However, four nonynonymous variants were identified
(Table 2), all of which were previously reported in dbSNP and had
high variant quality scores in our data. Among them, two alleles,
S680N and A307T, were common enough in frequency to be
tested for association with preterm birth. In particular, S680N is
likely functional since it was previously found to be associated with
the length of the menstrual cycle [24] and response to FSH
treatment [27]. However, neither S680N or A307T showed
significant association with preterm birth (Methods, two-propor-
tion Z-test, P = 1.0 and 0.86, respectively).
We observed two potentially functional nonsynonymous rare
variants, A189V and R162K in our samples. A189V was detected
at an allele frequency of 0.4% in the case pool and so is likely to be
heterozygous in a single individual. The A189V change disrupts
an evolutionarily conserved amino acid (P,1028 by the likelihood
ratio test [28] and probably damaging by PolyPhen-2 [29]) and is
a well-characterized inactivating mutation previously reported to
cause ovarian failure in homozygotes [30] and in a compound
heterozygote with A419T [31]. Another variant R162K is two-fold
over-represented in controls (2.6%) relative to cases (1.3%),
although the difference is not significant. Although PolyPhen-2
predicts R162K as benign, the mutated residue is marginally
conserved across mammals according to the likelihood ratio test
(P = 0.0017), and despite the biochemical similarity between
arginine and lysine, lysine was not observed at the orthologous
position of 18 placental mammals.
No Enrichment of Rare Variants in Cases
Although an individual rare variant can explain only a small
fraction of the risk for a common genetic disorder, rare variants
can still make a substantial aggregate contribution to risk [32],
[33]. To test if rare variants in FSHR are enriched in preterm
mothers, we compared the distribution of rare single nucleotide
variants (SNVs), defined by a minor allele frequency less than 1%,
between cases and controls. Using either all rare SNVs or rare
SNVs at conserved sites, defined by PhyloP (P,0.05) [34], we
found no enrichment in cases compared to controls (Table 3).
To increase the power of the analysis we used several less
restrictive sets of rare variants. When the sensitivity of variant
detection was maximized at the expense of specificity by lowering
the variant quality score cut-offs, a similar number of rare SNVs
was found in cases and controls (Table 3). We also found no
enrichment of SNVs present exclusively in cases or controls and
with minor allele frequencies up to 5% (Table S1). To control for
any differences in the sensitivity of detection or sample size we
compared SNVs in candidate regions to those within sequences
flanking the candidate regions (Table 3 and Table S1). However,
Figure 1. Allele frequencies estimated from pooled sequencing
in comparison to Affymetrix genotyping. Allele frequencies for
cases (red triangles) and controls (blue circles) are shown for 24 SNPs
shared between the two assays. The Affymetrix genotype data are from
[16].
doi:10.1371/journal.pone.0078032.g001
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flanking sequences showed similar numbers of SNVs in each
comparison.
Fine-mapping the Association of Common Variants
A previous study by Plunkett et al. (2011) identified three
common tag SNPs, rs11686474, rs11680730 and rs12473815, that
were significantly associated with preterm birth with odds ratios of
1.76–1.82 in a Finnish cohort. We observed a slight decline in the
odds ratios of these same tag SNPs to 1.58–1.59. The lower odds
ratios are due to subtle differences in allele frequency estimates
between the two studies as this study only included a subset of
subjects from the earlier report. We estimated the minor allele
frequency of the three SNPs to be 38.9, 39.7 and 41.7% in cases
and 28.6, 29.3 and 31.2% in controls whereas the previous study
reported a frequency of 41.6, 41.2 and 42.5% in cases and 28.5,
28.5 and 29.9% in controls.
To fine-map the association of FSHR with preterm birth, 169
common variants in sequenced regions were tested for allelic
association (Figure 2). The common variants were defined by a
minor allele frequency .5% and included 17 InDels and 152
SNPs. The candidate regions included 17 kb of all sequenced
regions (39%) and harbored 52 of the common variants (30.8%).
We reasoned that a potentially causal variant would exhibit an
association at least as strong as the three tag SNPs that were
previously identified. Out of 169 tested variants, 11 SNPs had
association stronger than the tag SNPs (two proportion Z-test,
P,0.05). All 11 associated SNPs were non-coding and localized to
a 103 kb region spanning intron 1 and 2 of FSHR. The SNP with
the highest association (rs12052281) was located in a conserved
non-coding element in intron 2 (two-proportion Z-test, P = 0.026).
To explore linkage disequilibrium within the fine-mapped
interval bounded by the 11 associated SNPs, we examined the
haplotypes of 93 normal Finns (FIN) from the 1000 Genomes
Project Consortium (Figure 3, Methods). Within a total of 9 kb
sequenced inside the 103 kb fine-mapped interval, 39 SNPs
occurred at a minor allele frequency over 5% and clustered into
four major haplotypes in FIN. These four haplotypes constitute
77% of chromosomes in FIN; the rest were either rare
haplotypes below 5% frequency or could not be directly tagged
by a known allele within the sequenced regions. All of the four
haplotypes are in linkage disequilibrium with the three tag SNPs
that were originally discovered to be associated with preterm
birth (D9=1.0) [16], but they have low r2 (0.28, 0.06, 0.32 and
0.38, respectively).
To estimate the frequencies of these haplotypes in cases and
controls, we utilized 21 SNPs tagging one of the four haplotypes
with r2.0.9 in FIN (Figure 4, Methods). Based on the genetic
homogeneity of Finns, we assumed that the linkage disequilib-
rium was consistent across FIN and our Finnish preterm and
term cohorts. Haplotype 1 showed a significant risk promoting
effect (Fisher’s exact test, P = 0.0074, OR=2.03, 95%
CI= 1.17–3.53), and haplotype 2 showed a significant protective
effect (P = 0.010, OR=0.42, 95% CI= 0.21–0.85). The fre-
quencies of haplotype 3 and 4 were not significantly different
between cases and controls. To test if the effects of haplotype 1
and 2 are independent from each other, we re-examined the
association of haplotype 1 with preterm birth after excluding
haplotype 2 from the gene pool, and vice versa. The odds ratios
for both haplotypes (OR=1.87 and 0.48, respectively) remained
similar after the correction and were significantly different from
1.0 (Fisher’s exact test, P = 0.020 and 0.023, respectively). The
Table 1. Summary statistics of sequencing and identified genetic variants.
High-quality SNVs1 Low-quality SNVs1
Pool Alleles (2N) Reads Coverage2 SNV InDel All3 SNV InDel All3
Case #1 192 34,940,358 74.7 198 42 240 (30) 29 16 45 (44)
Case #2 62 30,017,566 198.7 191 38 229 (60) 19 16 35 (34)
Control #1 150 32,513,156 89.0 202 41 243 (38) 30 13 43 (42)
Control #2 120 35,190,219 120.4 197 36 233 (33) 27 16 43 (43)
Total 524 132,661,299 103.9 236 45 281 52 20 72
1The number includes single nucleotide variants found in flanking regions as well as in candidate regions.
2Reads per site per allele.
3In parenthesis is the number of variants with the estimated allele count less than or equal to 2 in a pool.
doi:10.1371/journal.pone.0078032.t001
Table 2. Nonsynonymous SNVs identified in subjects.
Minor allele frequency
Variant
Amino acid
change
Functional
Prediction1 Case Control OR P allelic2
rs6166 S680N Neutral 0.480 0.480 1.00 1.00
rs6165 A307T Neutral 0.502 0.512 0.98 0.86
rs121909658 A189V Deleterious 0.004 0.000 n.a. not tested
rs111883853 R162K Marginal 0.013 0.026 0.50 not tested
1Functional predictions were made using a likelihood ratio test.
2P-values were calculated using a Z test.
doi:10.1371/journal.pone.0078032.t002
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three tag SNPs previously used by Plunkett et al. (2011) captured
both haplotype 1 and 2 simultaneously, with one allele tagging
the risk promoting haplotype and the other tagging the
protective haplotype.
To validate the accuracy of the estimated haplotype frequencies
we genotyped a set of 12 SNPs across all the samples. Consistent
with the haplotype frequencies estimated by sequencing, SNPs
tagging haplotypes 1 and 2 were associated with preterm birth
(Table S2). Excluding nine individuals with recombinant haplo-
types, both haplotypes were significant (Generalized linear model,
P,0.05), with an odds ratio of 1.89 (CI = 1.08–3.39, P= 0.0131)
for haplotype 1 and 0.50 (CI = 0.25–0.93, P= 0.0343) for
haplotype 2. Retaining the nine individuals and conducting the
test on each of the three risk and three protective SNPs produced
similar results (Table S2).
Table 3. Rare SNVs found in candidate regions.
Case Control
Variant quality Region1 Number2 Collapsed AF Number2 Collapsed AF OR3 P4
high all 8 3.2% 11 7.0% 0.44 0.03
conserved sites 5 2.0% 6 4.1% 0.47 0.13
high+low all 18 6.4% 18 8.6% 0.73 0.21
conserved sites 6 2.6% 9 4.7% 0.54 0.16
high flanking controls 13 7.0% 12 6.8% 1.04 n.a.
1Rare variants were counted in ‘‘all’’ candidate regions or only in ‘‘conserved sites’’ within candidate regions.
2The rare variants are defined by minor allele frequency below 1% in both case and control groups.
3Odds ratio of collapsed rare variant frequency in cases relative to controls.
4One-tail Fisher’s exact test of the collapsed allele frequencies between cases and controls.
doi:10.1371/journal.pone.0078032.t003
Figure 2. Fine-map of the association between common variants and preterm birth. Each of 169 variants with minor allele frequency
greater than 5% was tested for the allelic association with pre-term birth using a two-proportion Z-test. The log10 of the P-value is shown for each
SNP ordered by is position at the FSHR locus, shown above, with lines indicating intron boundaries and red ticks indicating the positions of 67
candidate regions sequenced. Bars are red for SNPs within candidate regions, gray for SNPs in flanking regions, and blue for those found significant in
[16]. The dashed horizontal line indicates the least significant P-value of the three tag SNPs in blue.
doi:10.1371/journal.pone.0078032.g002
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Candidate Causal Variants in Risk and Protective
Haplotypes
A potential causal risk variant is likely to be exclusively carried
by the risk promoting haplotype and not by haplotypes for which
we found protective or no effects. In the risk promoting haplotype,
six variants satisfying this criterion were found in the 9-kb of
sequenced regions within the fine-mapping interval (Figure 3).
Note that one of these variants (rs62162101) was moved to
chromosome 5 in the latest version of the human genome (NCBI
37) and so was eliminated from our analysis. For each variant, we
examined evolutionary conservation at the site, disruption of
potential transcription factor binding sites, and functional
sequences defined by ENCODE (Methods). Out of the five
candidate variants, we identified two in conserved non-coding
elements defined by PhastCons, and only one out of the two,
rs12052281, was found at a conserved nucleotide defined by
PhyloP (P,0.05). None of the variants occurred within potential
regulatory sequences defined by ENCODE.
The risk allele of rs12052281 (G) was a derived allele and
predicted to impact the binding of the transcriptional repressor
ZEB1 by 12.5% (Methods) [35]. A previous study identified ZEB1
as a key suppressor of genes involved in uterine contraction in both
humans and mice [36]. FSH, the ligand recognized by FSHR, is
known to modulate the electrical signaling property of the uterine
muscle [20]. Thus, the weaker binding of ZEB1 in the presence of
the G allele may cause de-repression of FSHR.
Similarly, the protective haplotype contained seven variants
which were not shared with other haplotypes of risk or no effect
(Figure 3). Although none of those variants was located within
potential regulatory sequences defined by ENCODE or sequence
elements conserved across placental mammals, rs72827283 and
rs72822025 were within noncoding element founds to be
conserved across primates by PhastCon. In particular, the
rs72822025 A allele of the protective haplotype occurred within
a predicted ELF3 binding motif defined by a protein-binding
microarray and is predicted to reduce the binding energy by
27.1% [37]. In mice, Elf3 is up-regulated during late pregnancy
Figure 3. Haplotype structure of common SNPs within the fine-mapped interval. Each row corresponds to a phased chromosome from 93
Finnish individuals in the 1000 Genomes Project. Each column represents one of the 39 SNPs that are segregating in the sequenced regions and also
in the fine-mapped interval spanning intron 1 and 2. Derived alleles at conserved sites are shown in gray scale with black being the most highly
conserved sites by PhyloP and white showing the ancestral allele. The four major haplotypes are numbered and color coded on the right such that
SNPs carried exclusively by one of the four haplotypes have the same label color on the bottom. The three tag SNPs evaluated in [16] are labeled in
dark blue.
doi:10.1371/journal.pone.0078032.g003
Figure 4. Haplotype frequencies in case and control pools. The
haplotype frequencies were estimated from allele frequencies of tag
SNPs with r2.0.9 (N = 9, 6, 3 and 3 for haplotype 1, 2, 3 and 4,
respectively). The horizontal line indicates the average allele frequency
among tag SNPs. The difference in allele frequency between cases and
controls was tested by Fisher’s Exact Test. NS denotes ‘‘not significant.’’
doi:10.1371/journal.pone.0078032.g004
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and activates the prostaglandin synthesis pathway in the uterus
through transcriptional activation of COX-1 [38].
Discussion
To refine a previously reported association between FSHR and
preterm birth, we conducted a sequencing-based fine-mapping
study in a Finnish population. We ruled out variation in the
protein-coding region and found independent associations with
both a risk promoting and a protective haplotype that span a
,100 kb region of intron 1 and 2 of FSHR. While we found
potentially functional binding site variants within both of these
haplotypes, our fine-mapping resolution was limited by high levels
of linkage disequilibrium across the region within the Finnish
population. As discussed below, our results provide insight into the
heterogeneous associations previously observed between FSHR
and preterm birth [16].
Rare Variants
One advantage of sequencing over genotyping is the ability to
identify rare, potentially functional variants in patient samples. In
FSHR, there are a number of rare mutations known to cause
reduced fertility or ovarian hyperstimulation syndrome [39],
which may be risk factors for preterm birth, e.g. [40], [41]. In
this study, we found few rare variants within coding or conserved
noncoding regions and no enrichment of these rare variants in
preterm birth cases compared to controls. Three of the rare SNVs
altering nonsynonymous or conserved non-coding sites were only
found in preterm mothers and had a combined frequency of 3.6%
(Table S3). One of the variants (A189V) was previously associated
with ovarian failure [30], [31]. One of the non-coding variants is
located at chr2:49,202,765 in a putative binding site for
peroxisome proliferator-activated receptor alpha (PPARA), which
has been implicated with preterm birth complicated with infection
[42]. The other non-coding variant with MAF of 2.4% is located
at chr2:49,202,863 in a putative binding site for SOX transcrip-
tion factors and SOX4 was observed to be differentially regulated
in the uterus of mice and to a lesser degree in humans [38].
Common Variants
Within the 796 kb region of the FSHR locus that was surveyed,
we found the strongest associations within a 103 kb region within
intron 1 and 2. This region does not include a common SNP
(S680N) previously associated with time to ovulation, length of the
menstrual cycle [24], and response to FSH treatment [27].
Because this SNP showed no enrichment in cases compared to
controls we can exclude the possibility that it influenced the
estimated length of gestation by altering the timing of fertilization.
Within the 103 kb region, we found high levels of linkage
disequilibrium and two low frequency haplotypes associated with
preterm birth; one with a risk promoting effect (MAF=12.6%,
OR=1.89) and the other with a protective effect (MAF=9.1%,
OR=0.50). We validated the independent effects of these
haplotypes by individually genotyping a subset of SNPs marking
these haplotypes and conducting a combined analysis. While the
high level of linkage disequilibrium made it difficult to resolve the
association to a smaller region of interest, we identified a number
of variants of interest through a bioninformatics analysis of
transcription factor binding sites.
Each of the two associated haplotypes has variants that alter
potential transcription factor binding sites present within con-
served noncoding regions. Two of the variants are noteworthy.
The risk promoting haplotype has a weaker ZEB1 binding site and
ZEB1 is involved in maintaining uterine quiescence through
progesterone receptor activation [36]. The protective haplotype
has a weaker ELF3 binding site and ELF3 increases in expression
during pregnancy in mice, activating prostaglandin biosynthesis
[38]. However, we cannot rule out the possibility of other
potentially functional variants outside of our sequenced regions,
which included only ,16% of the fine-mapped interval of intron 1
and 2. Although conserved intronic and intergenic regions in
FSHR are known to be enriched with cis-regulatory elements [43],
[44], non-conserved regions can contain transposable element
insertions which can modulate gene expression.
What can Explain Population-specific Associations
between FSHR and Preterm Birth?
FSHR was previously found associated with preterm birth in a
Finnish and African American population but not in a European
American or Hispanic American population [16]. One potential
explanation for this observation is that the causative allele(s) have
different frequencies in different populations. Consistent with this
possibility, the protective haplotype is at much lower frequency
outside of the Finnish population. As ascertained by the 1000
Genomes Project [45], the three SNPs that we used to tag the
protective haplotype (rs12465603, rs17038097, rs72822025) are at
lower frequency in other European (CEU: 2.9–4.1%, GBR: 2.8%,
IBS: 0%, TSI: 2.6%) and African (ASW: 1.6%, YRI: 0%, LWK:
0.5–3.1%) populations compared to the Finnish population (9.7–
13%), which is similar to the frequency of these SNPs in our
Finnish control samples (12–14%). Interestingly, the frequency of
these SNPs is much higher in Hispanic/American populations
(MXL: 22–38%, CLM: 9.1–11%, PUR: 9.1–11%). Of note, the
frequency of preterm birth is low in both Finland (5.5%) and
Mexico (7.3%) compared to the global average (11.1%) [46]. The
three SNPs that we used to tag the risk haplotype (rs10865237,
rs12614875, rs1504183) are at similar or higher frequencies in
other European (15–16%), African (11–34%) and Hispanic/
American (20%) populations compared to the Finnish (14%) and
our control samples (9.1–11%). Thus, we can expect the near
absence of the protective haplotype in some populations to weaken
the power of association with common tag SNPs.
Another factor that could lead to different associations in
different populations is linkage disequilibrium. While the three
SNPs we used to tag the protective and risk haplotypes have a
strong r2 in the Finnish, an average of 0.94 and 0.82, respectively,
they have much lower correlations in European (0.48) and African
(0.66) populations, respectively. The lower r2 between SNPs that
tag the risk haplotype occurs in other European (r2 = 0.78) and
Hispanic/American (r2 = 0.72) populations, but is most pro-
nounced in African populations (r2 = 0.18). The average r2
between the three SNPs that tag the risk haplotype and the three
common tag SNPs found significant in Plunkett et al. (2011) is 0.26
in the Finnish population but 0.17 in other European populations,
0.17 in African populations and 0.28 in Hispanic/American
populations. Thus, linkage disequilibrium is reduced in some
populations.
In summary, both the reduced frequency of the protective
haplotype and reduced levels of linkage disequilibrium provide an
explanation for the absence of association between FSHR and
preterm birth outside of Finnish cohorts. While this observation
provides one explanation for the absence of association in
European American populations it does not explain the absence
of association in Hispanic American populations or the presence of
association in African American populations. Both haplotype
frequencies and linkage disequilibrium are reduced in African
populations but not reduced in Hispanic populations. Thus, while
Finnish cohorts are advantageous due to population homogeneity
FSHR and Preterm Birth
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and high levels of linkage disequilibrium, they can be disadvan-
tageous when trying to replicate associations in other populations.
Conclusions
Using a sequenced-based, fine-mapping approach, we have
shown that a previous association between FSHR and preterm
birth is best explained by a risk promoting and protective
haplotype that extend over ,100 kb of intron 1 and 2. Our work
highlights the challenges of fine-mapping linkage disequilibrium-
based associations, which is important to understanding hetero-
geneous associations across populations and the mechanisms by
which genetic variants influence phenotypes of interest.
Materials and Methods
Candidate Regions
Candidate regions covering a total of 17 kb were selected based
on an increased likelihood of containing functional variants. These
regions include: all exons (NM_000145), 50-bp exon-intron
junctions, core promoter region (21 to 2225 relative to the
translational start site) [47], 3 SNPs found significantly associated
with preterm birth in African Americans (rs11686474, rs11680730
and rs12473815) [16], 15 non-coding elements rapidly evolved
along the human lineage [16], and conserved non-coding elements
(Table S4). Conserved non-coding elements, a total of 8.6 kb
(N= 269), were identified within the transcribed region and 5 kb
upstream and downstream, based on the sequence conservation
across 32 placental mammals using PhastCons [25]. A PhastCons
element was selected as a candidate if it was longer than 50 bp by
itself or a part of a cluster of PhastCons elements separated by less
than 200 bp and together span more than 50 bp. In addition to
PhastCons regions, we also included conserved functional non-
coding elements from the literature. One transcriptional silencer
[43] and seven distal transcriptional regulatory elements [44] were
previously identified in rat, and their sequences are well conserved
to human. The genomic coordinates of the rat non-coding
elements were transferred to the human genome with UCSC
LiftOver (http://genome.ucsc.edu/cgi-bin/hgLiftOver).
The candidate regions were amplified in 67 PCR amplicons
(44 kb). PCR primers were designed using Primer 3 (http://frodo.
wi.mit.edu/primer3/input.htm) with a minimum amplicon size of
300 bp and other parameters previously described [48], [49]. To
avoid allele-specific PCR failure, PCR primers were selected
within polymorphism-free segments utilizing the 1000 Genomes
Project data [45].
Ethics Statement
The study of human subject was approved by Institutional
Review Boards and Ethics Committees at Helsinki University
Central Hospital and Washington University. Informed consent
for the genetics research was obtained in writing.
Human Subjects
The human subjects investigated in this study largely overlap
with the Finnish mothers in which the association of FSHR was
originally identified [16]. Out of 127 preterm and 135 term
mothers investigated in this work, 96 cases and 70 controls were
shared with the previous study, and the rest were unique to this
study. The inclusion criteria for preterm mothers was a non-
atrogenic singleton pregnancy with less than 37 completed weeks
of gestation without a sign of trauma, infection, or drug abuse.
Controls were mothers who delivered spontaneously after 37
gestational weeks, with no other pregnancies delivering preterm or
first degree family members born preterm. There was no
difference in the average maternal age between cases (30.6 years)
and controls (31.4 years) (Wilcoxon test, P = 0.17). The sample
genomic DNA was collected from peripheral bloods or saliva using
standard methods.
Pooled High-throughput Sequencing
Human subjects were placed into four groups by case/control
status and by whether an individual was also included in a
previous study [16] or not. For each group, an Illumina
sequencing library was prepared following the pooled high-
throughput sequencing protocol [50], [51]. Although this protocol
cannot assay individual genotypes, single nucleotide variants
(SNVs) and 1–2 bp insertions/deletions (InDels) can be efficiently
identified with the high sensitivity and specificity along with their
allele frequencies [50], [51]. Briefly, genomic DNA samples in
each group were fluorescently quantified using SYBR Gold
(Invitrogen) staining technique [51], and mixed into an equimolar
pool. To average out stochastic noise, we prepared two technical
replicates of pooled genomic samples and repeated all of the
subsequently described steps.
In each pool, the candidate regions were amplified by PCR with
PfuUltra High-Fidelity DNA polymerase (Stratagene) in the
presence of 1M betaine (Sigma-Aldrich). In each PCR reaction,
0.3N ng of pooled genomic DNA was added as templates, where N
is the number of pooled individuals. While the number of PCR
cycles was fixed to 28, other PCR parameters were optimized for
each amplicon (Table S5). All PCR products were purified on
QIAquick spin columns (Qiagen), validated on agarose gel and
then quantified again by SYBR Gold staining.
To control for the sensitivity and specificity of pooled
sequencing, we prepared positive and negative controls as
described previously [51]. The negative control was a 1.9 kb
region of M13mp18 plasmid (NEB), and positive controls were
335-bp synthetic sequences derived from TP53 (shared by F. L. M.
Vallania). Seven positive control plasmids carrying a total of 13
known mutations were spiked into unmutated plasmid DNA at the
lowest allele frequency of each pool (1/2N). Both positive and
negative controls were PCR-amplified similar to candidate
regions.
Amplicons of candidate regions and controls were pooled in an
equimolar ratio so that all regions were sequenced at an even read
coverage. The pooled amplicons were randomly ligated into
.10 kb concatemers and then sonicated into 100–500 bp
fragments with a Bioruptor XL (Diagenode) following [50]. From
the sonicated fragments, Illumina sequencing libraries were
generated using the Genomic DNA Sample Prep Kit (Illumina).
Each library was tagged with an index unique to each subject
group. To minimize run-specific variation in error rates, all four
sequencing libraries were multiplexed and sequenced on a single
Illumina HiSeq lane in a single-read 42-cycle mode.
Identification of Single Nucleotide Variants
For each pool, 42-bp sequence reads were mapped, aligned,
calibrated and then scanned for single nucleotide variants (SNVs)
and 1–2 bp insertions/deletions (InDels) using SPLINTER
(version 6t) [51]. Out of 35.8–40.4 million reads, 30.0–35.2
miilion (84–88%) were aligned to the reference sequence (hg18)
allowing two or less edits per read in the alignment. To calibrate
sequencing error rates, a second-order SPLINTER error model
was generated from the reads aligned to the negative control
sequence. Overall, the error rates were substantially higher at 23
sequencing cycles compared to the rest of cycles. After masking out
all such error-prone cycles, only high-quality basecalls (19 nt per
read) were utilized to identify SNVs.
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The power to detect SNVs goes up with an increasing read
coverage but saturates above,30 reads per site per allele [51]. We
obtained 74.7–198.7 reads per site per allele on average for each
pool, which is well above the saturation point. However, the read
coverage was still less than 30 reads per site per allele at 2.1% of
sites, either due to random sampling or difficulty in alignment.
These regions are located in two rapidly evolving elements, a rat
distal cis-regulatory element (ECR6) and a variable poly-dA region
(11–17 bp) in the core promoter.
The optimal cut-offs for SNV calls were determined by positive
and negative controls spiked into the sequencing library. In all
pools, SNV quality scores of positive controls were well separated
from those of negative controls; thus there exist a range of score
cut-offs discriminating positive from negative controls with 100%
accuracy. We defined SNV sets at high and lower variant quality
thresholds to maximize the specificity and the sensitivity,
respectively. For each pool, the high quality cut-off was defined
by the lowest variant quality score of positive controls whereas the
lower quality cut-off was defined by the highest variant quality
score of negative controls. After excluding a tri-allelic variant, we
obtained a total of 281 high-quality SNVs and 72 lower-quality
SNVs across all pools. The allele frequency estimates by
SPLINTER were rounded off to the nearest multiple of a
singleton allele frequency in each pool.
We validated the power and accuracy of variant identification in
three ways. First, using spike-in plasmid controls we found that
positive controls added at the singleton allele frequency were all
recovered with no false positive. Second, a large proportion of
SNVs identified in our subjects are variants also present in the
dbSNP database (release 135). The known variants were highly
enriched among both of the high- and lower-quality SNVs (93.0%
and 38.1%, respectively) compared to raw sequence variants
which did not satisfy variant detection criteria (1.0%). Third, the
estimated allele frequencies were compared to 24 SNPs that were
previously genotyped with Affymetrix microarrays in a largely
overlapping set of individuals [16].
Comparison of Allele Frequencies between Cases and
Controls
Significant differences in allele frequency between cases and
controls were tested for all common variants of minor allele
frequency over 5% using a two-proportion Z-test:
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where pA and pB are the allele frequencies in cases and controls,
respectively, NA and NB are the number of alleles in case and
control pools, respectively, p0 is the pooled allele frequency over pA
and pB, ss is the variance component due to random sampling,
and the statistic z follows the standard normal distribution. Unlike
a usual two-proportion Z-test, we had to account for the error of
allele frequency estimation as an additional source of variation
independent of random sampling. The error of allele frequency
estimation se was inferred from the mean squared error of
observed allele frequencies compared to the expected values using
24 SNPs genotyped in the Finnish cohort with Affymetrix arrays
[16]:
se ~
1
24
X24
i~1
fo,i{fe,ið Þ2
where fo,i and fe,i are the observed and expected allele frequencies
of SNP i, respectively. The se was estimated to be 0.00081 for cases
and 0.00032 for controls.
Haplotype Analysis
The haplotype structure of Finnish population was obtained
from the 1000 Genomes Project (release 20120316) [45], in which
genotypes of 93 individuals (FIN) were phased across the genome
using MaCH/Thunder [52]. Ancestral alleles inferred from three
sister primate genomes were also obtained from the 1000
Genomes Project. Conserved sites were identified using PhyloP
scores across placental mammals [34], which were downloaded
from the UCSC genome browser.
The haplotype frequencies were estimated in our case and
control subjects by averaging the allele frequencies of multiple tag
SNPs, which were selected by tight linkage disequilibrium between
the SNP and the haplotype. Specifically, we looked for SNPs with
r2 greater than 0.9 in Finns from the 1000 Genomes Project (FIN).
For haplotype 1, excluding one outlier, nine tag SNPs were
utilized to quantify the haplotype frequency. The frequencies of
haplotype 2, 3 and 4 were estimated using six, three and three tag
SNPs, respectively.
Haplotype frequency was validated by genotyping 12 SNPs
across all samples. The 12 SNPs include three that tag the risk
haplotype and three that tag the protective haplotype. Individual
DNA samples were genotyped for each SNP by Sequenom
massARRAY technology at the Human Genetics Division’s
Genotyping Core Facility at Washington University. Genotype
data are provided in Table S6. Four individuals (1 case and 3
controls) were excluded due to low genotyping quality. The
average difference between the pooled allele frequency estimates
and the genotype-based frequencies was 1.45% for cases and
0.95% for controls, excluding one marker (rs3913665) for which
the minor allele frequency was 31.7% in cases and 34.6% in
controls by sequencing and 35.7% in cases and 40.2% in controls
by genotyping. Recombinant haplotypes were detected in nine
individuals (two cases and seven controls) based on the SNPs used
to tag either the protective or risk haplotypes. These nine
individuals cause slight differences in P-values and LD of SNPs
tagging a haplotype (Table S2). LD relationships and P-values are
identical if these nine individuals are removed. A generalized
lineage model with a binomial error distribution was used to test
for significant effects of both the risk and protective haplotypes.
Computational Prediction of Transcription Factor Binding
Sites
We examined three databases of transcription factor (TF)
binding profiles: TRANSFAC [53], JASPAR [54] and UniProbe
[55]. TRANSFAC contains the most comprehensive collection of
TF binding profiles, JASPAR has fewer but higher-quality profiles,
and UniProbe encompasses mostly zinc finger binding motifs,
which were derived from in vitro protein-binding microarray
experiments. In TRANSFAC (version 10.2), the human reference
sequences with ancestral alleles were scanned for binding sites of
vertebrate TFs using the ECR browser (http://ecrbrowser.dcode.
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org/) [56]. In JASPAR, the CORE Vertebrata collection of
binding matrices was examined using its web server (http://jaspar.
cgb.ki.se/) with the default parameters. In UniProbe, human and
mouse TFs were scanned with the default setting (http://
the_brain.bwh.harvard.edu/uniprobe/), but SNPs with more than
20 hits of predicted binding sites were filtered out for potential
non-specificity. For JASPAR and UniProbe, the reference
sequences were examined with both derived as well as ancestral
alleles in order to explore the gain as well as loss of binding sites.
The binding sites predicted with the equivalent score for both
ancestral and derived alleles were excluded. The binding energy
for ZEB1 and ELF3 was calculated for each allele using ConSite
[57] with the default parameter values and published binding site
profiles [35,37].
Analysis of ENCODE Data
ENCODE data was used to identify potential regulatory SNPs
[58]. We classified SNPs as potentially involved in gene regulation
if they occurred in open chromatin, defined by DNaseI
hypersensitive sites from 125 cell lines or FAIRE, or if they
occurred in bound sequences from 194 Chip-seq experiments that
make up the ENCODE regulatory track from Yale/UC-Davis/
Harvard. Out of the 5 variants unique to the risk haplotype and 7
variants unique to the protective haplotype, none occurred in
potential regulatory sequences defined by ENCODE.
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